Proteomics Research and Technologies Forecasted to Grow at Significant Rates Through 2006 New research available at MindBranch

Williamstown, MA-March 15, 2002 -MindBranch, Inc., a leading provider of market research has seen a significant increase in studies focused on the proteomics sector in the healthcare industry. In the last 6 months, weve seen 6 new reports on this subject from our top tier research firm partners" says Kim Nelson, Director of Publisher Services for MindBranch.

The word proteomics is defined as the quantification of all proteins expressed at any individual time in a cell. The study of proteomics will be a key factor in the development of next generation blockbuster drugs according to Theta Reports, a market research firm whose studies concentrate on health care, medical devices and diagnostics, biotechnology, and pharmaceuticals. Theta believes the sales of systems for proteomics research will grow 30% per year through 2006.

Some of the new titles that focus on different aspects of the proteomics sector include:
-Proteomics 2002: Commercial & Technological Potentials, by Theta Reports
-Profiting from Proteomics: High-Throughput Expression, Functional Proteomics, Protein Chips, and Protein Informatics, by Cambridge Healthtech Institute
-Proteomics: Promising Research, Potential Applications, and New Developments, by Technical Insights
-Proteomics Market Profiles, by Frost & Sullivan

MindBranch believes this industry is poised for exponential growth and these reports feature in-depth research about the complexities of this burgeoning field. Rapid growth in the supply and demand for instruments and reagents will lead to a competitive landscape in the next few years. MindBranch and its research partners can help clients understand how to enter and compete in this market. The reports are ideal for decision-makers in the healthcare industry as well as investors in drug discovery -- including venture capitalists, new product development professionals, and equipment manufacturers.

Proteomics is shaping the future of drug discovery. Log on to www.mindbranch.com to stay up to speed.

About MindBranch
MindBranch, founded in 1992, is a market research services company providing research from 300 leading publishers such as The Freedonia Group, Cahners In-Stat and Datamonitor. Fortune 1000 companies in every major industry segment benefit from a single, objective source for all their syndicated, subscription, and custom research needs. For more information visit www.mindbranch.com. MindBranch is a majority-owned subsidiary of Village Ventures, Inc., Williamstown, Massachusetts.
Contact